{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T16:21:33Z","timestamp":1789662093641,"version":"4.0.1"},"reference-count":60,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","mayoclinicproceedings.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.mayocp.2020.10.005","type":"journal-article","created":{"date-parts":[[2021,3,2]],"date-time":"2021-03-02T00:53:26Z","timestamp":1614646406000},"page":"708-719","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["My Treatment Approach to Multiple System Atrophy"],"prefix":"10.1016","volume":"96","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1206-0222","authenticated-orcid":false,"given":"Elizabeth A.","family":"Coon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3393-5561","authenticated-orcid":false,"given":"J. Eric","family":"Ahlskog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.mayocp.2020.10.005_bib1","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1212\/WNL.49.5.1284","article-title":"Incidence of progressive supranuclear palsy and multiple system atrophy in Olmsted County, Minnesota, 1976 to 1990","volume":"49","author":"Bower","year":"1997","journal-title":"Neurology"},{"issue":"pt 12","key":"10.1016\/j.mayocp.2020.10.005_bib2","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1093\/brain\/awv274","article-title":"Clinical features and autonomic testing predict survival in multiple system atrophy","volume":"138","author":"Coon","year":"2015","journal-title":"Brain"},{"issue":"pt\u00a04","key":"10.1016\/j.mayocp.2020.10.005_bib3","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1093\/brain\/117.4.835","article-title":"Clinical features and natural history of multiple system atrophy. An analysis of 100 cases","volume":"117","author":"Wenning","year":"1994","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.mayocp.2020.10.005_bib4","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/mds.870120203","article-title":"Multiple system atrophy: a review of 203 pathologically proven cases","volume":"12","author":"Wenning","year":"1997","journal-title":"Mov Disord"},{"issue":"9","key":"10.1016\/j.mayocp.2020.10.005_bib5","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1212\/01.wnl.0000324625.00404.15","article-title":"Second consensus statement on the diagnosis of multiple system atrophy","volume":"71","author":"Gilman","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.mayocp.2020.10.005_bib6","first-page":"330","article-title":"'atrophie olivo-ponto-cerebelleuse","volume":"13","author":"Dejerine","year":"1900","journal-title":"Nouv Iconog Salpetriere"},{"key":"10.1016\/j.mayocp.2020.10.005_bib7","first-page":"584","article-title":"Striato-nigral degeneration","volume":"23","author":"Adams","year":"1964","journal-title":"J\u00a0Neuropath Exp Neurol"},{"key":"10.1016\/j.mayocp.2020.10.005_bib8","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1001\/archneur.1960.03840110025004","article-title":"A\u00a0neurological syndrome associated with orthostatic hypotension. A clinical-pathologic study","volume":"2","author":"Shy","year":"1960","journal-title":"Arch Neurol"},{"issue":"1","key":"10.1016\/j.mayocp.2020.10.005_bib9","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1136\/jnnp.32.1.28","article-title":"Orthostatic hypotension and nicotine sensitivity in a case of multiple system atrophy","volume":"32","author":"Graham","year":"1969","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"3","key":"10.1016\/j.mayocp.2020.10.005_bib10","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/ana.410440324","article-title":"Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble alpha-synuclein","volume":"44","author":"Tu","year":"1998","journal-title":"Ann Neurol"},{"issue":"17","key":"10.1016\/j.mayocp.2020.10.005_bib11","doi-asserted-by":"crossref","first-page":"e1828","DOI":"10.1212\/WNL.0000000000009372","article-title":"Progression and prognosis in multiple system atrophy presenting with REM behavior disorder","volume":"94","author":"Giannini","year":"2020","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.mayocp.2020.10.005_bib12","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1002\/mds.21992","article-title":"Red flags for multiple system atrophy","volume":"23","author":"Kollensperger","year":"2008","journal-title":"Mov Disord"},{"issue":"7","key":"10.1016\/j.mayocp.2020.10.005_bib13","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/mds.25880","article-title":"Cognitive impairment in multiple system atrophy: a position statement by the Neuropsychology Task Force of the MDS Multiple System Atrophy (MODIMSA) study group","volume":"29","author":"Stankovic","year":"2014","journal-title":"Mov Disord"},{"issue":"7","key":"10.1016\/j.mayocp.2020.10.005_bib14","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/S1474-4422(15)00058-7","article-title":"Natural history of multiple system atrophy in the USA: a prospective cohort study","volume":"14","author":"Low","year":"2015","journal-title":"Lancet Neurol"},{"issue":"8","key":"10.1016\/j.mayocp.2020.10.005_bib15","first-page":"1567","article-title":"The recommendations of a consensus panel for the screening, diagnosis, and treatment of neurogenic orthostatic hypotension and associated supine hypertension","volume":"264","author":"Gibbons","year":"2017","journal-title":"J\u00a0Neurol"},{"issue":"3","key":"10.1016\/j.mayocp.2020.10.005_bib16","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/ana.25170","article-title":"Orthostatic heart rate changes in patients with autonomic failure caused by neurodegenerative synucleinopathies","volume":"83","author":"Norcliffe-Kaufmann","year":"2018","journal-title":"Ann Neurol"},{"issue":"5","key":"10.1016\/j.mayocp.2020.10.005_bib17","first-page":"527","article-title":"Evaluation and management of orthostatic hypotension","volume":"84","author":"Lanier","year":"2011","journal-title":"Am Fam Physician"},{"issue":"4","key":"10.1016\/j.mayocp.2020.10.005_bib18","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s10286-018-0529-8","volume":"28","author":"Fanciulli","year":"2018","journal-title":"Clin Auton Res"},{"issue":"2","key":"10.1016\/j.mayocp.2020.10.005_bib19","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1080\/14656566.2018.1543404","article-title":"Chemical pharmacotherapy for the treatment of orthostatic hypotension","volume":"20","author":"Cheshire","year":"2019","journal-title":"Expert Opin Pharmacother"},{"issue":"1","key":"10.1016\/j.mayocp.2020.10.005_bib20","first-page":"76","article-title":"Midodrine. A review of its therapeutic use in the management of orthostatic hypotension","volume":"12","author":"McClellan","year":"1998","journal-title":"Drugs Aging"},{"issue":"4","key":"10.1016\/j.mayocp.2020.10.005_bib21","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1517\/14656566.1.4.835","article-title":"Midodrine: a selective alpha-adrenergic agonist for orthostatic hypotension and dialysis hypotension","volume":"1","author":"Cruz","year":"2000","journal-title":"Expert Opin Pharmacother"},{"issue":"5","key":"10.1016\/j.mayocp.2020.10.005_bib22","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/clpt.1986.101","article-title":"Pharmacodynamics of midodrine, an antihypotensive agent","volume":"39","author":"Zachariah","year":"1986","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.mayocp.2020.10.005_bib23","first-page":"119","article-title":"Pharmacokinetic parameters and haemodynamic actions of midodrine in young volunteers","volume":"12","author":"Grobecker","year":"1993","journal-title":"Int Angiol"},{"issue":"13","key":"10.1016\/j.mayocp.2020.10.005_bib24","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1001\/jama.1997.03540370036033","article-title":"Efficacy of midodrine vs placebo in neurogenic orthostatic hypotension. A randomized, double-blind multicenter study. Midodrine Study Group","volume":"277","author":"Low","year":"1997","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.mayocp.2020.10.005_bib25","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1212\/WNL.51.1.120","article-title":"A\u00a0double-blind, dose-response study of midodrine in neurogenic orthostatic hypotension","volume":"51","author":"Wright","year":"1998","journal-title":"Neurology"},{"issue":"suppl 1","key":"10.1016\/j.mayocp.2020.10.005_bib26","first-page":"1","article-title":"Droxidopa for symptomatic neurogenic orthostatic hypotension: what can we learn?","volume":"27","author":"Kaufmann","year":"2017","journal-title":"Clin Auton Res"},{"issue":"8","key":"10.1016\/j.mayocp.2020.10.005_bib27","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1586\/14779072.2015.1057504","article-title":"Droxidopa in neurogenic orthostatic hypotension","volume":"13","author":"Kaufmann","year":"2015","journal-title":"Expert Rev Cardiovasc Ther"},{"issue":"6","key":"10.1016\/j.mayocp.2020.10.005_bib28","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s10286-004-0221-z","article-title":"Clinical pharmacokinetics of the norepinephrine precursor L-threo-DOPS in primary chronic autonomic failure","volume":"14","author":"Goldstein","year":"2004","journal-title":"Clin Auton Res"},{"issue":"5","key":"10.1016\/j.mayocp.2020.10.005_bib29","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1097\/01.wnp.0000229946.01494.4c","article-title":"Acetylcholinesterase inhibition in patients with orthostatic intolerance","volume":"23","author":"Singer","year":"2006","journal-title":"J\u00a0Clin Neurophysiol"},{"issue":"4","key":"10.1016\/j.mayocp.2020.10.005_bib30","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1001\/archneur.63.4.noc50340","article-title":"Pyridostigmine treatment trial in neurogenic orthostatic hypotension","volume":"63","author":"Singer","year":"2006","journal-title":"Arch Neurol"},{"issue":"1","key":"10.1016\/j.mayocp.2020.10.005_bib31","doi-asserted-by":"crossref","first-page":"R40","DOI":"10.1152\/ajpregu.00544.2010","article-title":"The osmopressor response to water drinking","volume":"300","author":"May","year":"2011","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"2","key":"10.1016\/j.mayocp.2020.10.005_bib32","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1524-6175.2001.00516.x","article-title":"Diagnosis and treatment of supine hypertension in autonomic failure patients with orthostatic hypotension","volume":"4","author":"Jordan","year":"2002","journal-title":"J\u00a0Clin Hypertens (Greenwich)"},{"issue":"3","key":"10.1016\/j.mayocp.2020.10.005_bib33","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1161\/01.HYP.0000199982.71858.11","article-title":"Clonidine for the treatment of supine hypertension and pressure natriuresis in autonomic failure","volume":"47","author":"Shibao","year":"2006","journal-title":"Hypertension"},{"issue":"10","key":"10.1016\/j.mayocp.2020.10.005_bib34","doi-asserted-by":"crossref","first-page":"e946","DOI":"10.1212\/WNL.0000000000008053","article-title":"Urodynamic study for distinguishing multiple system atrophy from Parkinson disease","volume":"93","author":"Shin","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.mayocp.2020.10.005_bib35","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.autneu.2019.04.002","article-title":"Sex and gender influence symptom manifestation and survival in multiple system atrophy","volume":"219","author":"Coon","year":"2019","journal-title":"Auton Neurosci"},{"issue":"8","key":"10.1016\/j.mayocp.2020.10.005_bib36","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1056\/NEJM198402233100802","article-title":"The \"on-off\" phenomenon in Parkinson's disease: relation to levodopa absorption and transport","volume":"310","author":"Nutt","year":"1984","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.mayocp.2020.10.005_bib37","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1001\/archneur.1987.00520220012007","article-title":"Plasma levels of amino acids correlate wilth motor fluctuations in parkinsonism","volume":"44","author":"Pincus","year":"1987","journal-title":"Arch Neurol"},{"key":"10.1016\/j.mayocp.2020.10.005_bib38","series-title":"The New Parkinson's Disease Treatment Book","author":"Ahlskog","year":"2015"},{"issue":"2","key":"10.1016\/j.mayocp.2020.10.005_bib39","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/ana.410200212","article-title":"Inhibition of L-[18F]fluorodopa uptake into human brain by amino acids demonstrated by positron emission tomography","volume":"20","author":"Leenders","year":"1986","journal-title":"Ann Neurol"},{"issue":"5","key":"10.1016\/j.mayocp.2020.10.005_bib40","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1093\/ptj\/79.5.488","article-title":"Multiple system atrophy","volume":"79","author":"Swan","year":"1999","journal-title":"Phys Ther"},{"issue":"pt 2","key":"10.1016\/j.mayocp.2020.10.005_bib41","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1093\/brain\/awl357","article-title":"Depletion of putative chemosensitive respiratory neurons in the ventral medullary surface in multiple system atrophy","volume":"130","author":"Benarroch","year":"2007","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.mayocp.2020.10.005_bib42","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/1531-8257(200007)15:4<699::AID-MDS1015>3.0.CO;2-L","article-title":"Stridor and death in multiple system atrophy","volume":"15","author":"Silber","year":"2000","journal-title":"Mov Disord"},{"issue":"13","key":"10.1016\/j.mayocp.2020.10.005_bib43","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1212\/WNL.0000000000003156","article-title":"Early stridor onset and stridor treatment predict survival in 136 patients with MSA","volume":"87","author":"Giannini","year":"2016","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.mayocp.2020.10.005_bib44","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1001\/archneur.63.7.978","article-title":"Respiratory insufficiency as the primary presenting symptom of multiple-system atrophy","volume":"63","author":"Glass","year":"2006","journal-title":"Arch Neurol"},{"key":"10.1016\/j.mayocp.2020.10.005_bib45","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2014-206372","article-title":"Use of a new generation of adaptive servo ventilation for sleep-disordered breathing in patients with multiple system atrophy","volume":"2015","author":"Hamada","year":"2015","journal-title":"BMJ Case Rep"},{"issue":"6","key":"10.1016\/j.mayocp.2020.10.005_bib46","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1212\/WNL.0b013e3181ec7fac","article-title":"REM sleep behavior disorder preceding other aspects of synucleinopathies by up to half a century","volume":"75","author":"Claassen","year":"2010","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.mayocp.2020.10.005_bib47","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1136\/jnnp.72.3.300","article-title":"Dystonia in multiple system atrophy","volume":"72","author":"Boesch","year":"2002","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"9","key":"10.1016\/j.mayocp.2020.10.005_bib48","first-page":"CR427","article-title":"Anterocollis: clinical features and treatment options","volume":"14","author":"Papapetropoulos","year":"2008","journal-title":"Med Sci Monit"},{"issue":"6","key":"10.1016\/j.mayocp.2020.10.005_bib49","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1001\/archneur.1996.00550060089021","article-title":"Characteristics of the dysarthria of multiple system atrophy","volume":"53","author":"Kluin","year":"1996","journal-title":"Arch Neurol"},{"issue":"8","key":"10.1016\/j.mayocp.2020.10.005_bib50","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1002\/mds.20450","article-title":"Depressive symptoms and life satisfaction in patients with multiple system atrophy","volume":"20","author":"Benrud-Larson","year":"2005","journal-title":"Mov Disord"},{"issue":"1","key":"10.1016\/j.mayocp.2020.10.005_bib51","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/ane.12804","article-title":"Depression and anxiety in multiple system atrophy","volume":"137","author":"Zhang","year":"2018","journal-title":"Acta Neurol Scand"},{"issue":"6","key":"10.1016\/j.mayocp.2020.10.005_bib52","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1002\/mds.20808","article-title":"Health-related quality of life in multiple system atrophy","volume":"21","author":"Schrag","year":"2006","journal-title":"Mov Disord"},{"issue":"6","key":"10.1016\/j.mayocp.2020.10.005_bib53","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1002\/mds.21348","article-title":"Pathological laughter and crying in patients with multiple system atrophy-cerebellar type","volume":"22","author":"Parvizi","year":"2007","journal-title":"Mov Disord"},{"issue":"5","key":"10.1016\/j.mayocp.2020.10.005_bib54","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1002\/ana.22093","article-title":"Dextromethorphan plus ultra low-dose quinidine reduces pseudobulbar affect","volume":"68","author":"Pioro","year":"2010","journal-title":"Ann Neurol"},{"key":"10.1016\/j.mayocp.2020.10.005_bib55","doi-asserted-by":"crossref","first-page":"3150306","DOI":"10.1155\/2019\/3150306","article-title":"A\u00a0comparison of pain between Parkinson's disease and multiple system atrophy: a clinical cross-sectional survey","volume":"2019","author":"You","year":"2019","journal-title":"Pain Res Manag"},{"issue":"2","key":"10.1016\/j.mayocp.2020.10.005_bib56","first-page":"153","article-title":"Pain in multiple system atrophy","volume":"243","author":"Tison","year":"1996","journal-title":"J\u00a0Neurol"},{"key":"10.1016\/j.mayocp.2020.10.005_bib57","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.parkreldis.2016.10.013","article-title":"Palliative care and its emerging role in multiple system atrophy and progressive supranuclear palsy","volume":"34","author":"Wiblin","year":"2017","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.mayocp.2020.10.005_bib58","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.parkreldis.2019.09.026","article-title":"Physiotherapy improves motor function in patients with the Parkinson variant of multiple system atrophy: a prospective trial","volume":"67","author":"Raccagni","year":"2019","journal-title":"Parkinsonism Relat Disord"},{"issue":"3","key":"10.1016\/j.mayocp.2020.10.005_bib59","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.mayocp.2017.12.015","article-title":"Aerobic exercise: evidence for a direct brain effect to slow Parkinson disease progression","volume":"93","author":"Ahlskog","year":"2018","journal-title":"Mayo Clin Proc"},{"issue":"9","key":"10.1016\/j.mayocp.2020.10.005_bib60","doi-asserted-by":"crossref","first-page":"876","DOI":"10.4065\/mcp.2011.0252","article-title":"Physical exercise as a preventive or disease-modifying treatment of dementia and brain aging","volume":"86","author":"Ahlskog","year":"2011","journal-title":"Mayo Clin Proc"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619620311836?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619620311836?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T05:37:15Z","timestamp":1768369035000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619620311836"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":60,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S0025619620311836"],"URL":"https:\/\/doi.org\/10.1016\/j.mayocp.2020.10.005","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"My Treatment Approach to Multiple System Atrophy","name":"articletitle","label":"Article Title"},{"value":"Mayo Clinic Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mayocp.2020.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Mayo Foundation for Medical Education and Research","name":"copyright","label":"Copyright"}]}}